retatrutide clinical trial weight loss data VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide Results: How Much Weight
Description
d , GLP-1 receptor (GLP-1R) beta-arrestin activity test data (n = 3 per group) (exendin-4: GLP-1R agonist)
We walk through year one cost math, the February 2026 FDA enforcement context, Ros December 2025 peer-reviewed outcomes paper, and what the Wegovy pill (FDA-approved December 2025) changes for needle-phobic buyers
Gradual dose titration remains one of the most effective approaches
And finally 12mg for those randomized to the highest dose group
But for now, that promise remains largely unproven
